NESTcc has announced that it has officially opened for the management of sponsor-funded research projects to advance the use of real-world data (RWD) in medical device evaluation. The public launch of NEST 1.0 is a key inflection point in the maturity of NESTcc, signifying both the demonstrated capabilities of our Research Network and the strategic […]
NESTcc has announced the addition of six new members of its Governing Committee. The NESTcc Governing Committee is comprised of stakeholders from across the medical device ecosystem committed to the success of NESTcc and, upon inception, was charged with inaugurating a Coordinating Center that is inclusive, patient-focused, and anchored in accountability and transparency. NESTcc’s new […]
The Medical Device Innovation Consortium (MDIC) today announced that Flora Sandra Siami, MPH, has joined the organization as Senior Vice President for NESTcc. As SVP of NESTcc, Ms. Siami will guide the strategy and operations for NESTcc programs to advance the goals of stakeholders including patients, providers, payers, industry, regulators, and others. She will lead […]
NESTcc Test-Case insights from Johnson & Johnson and Network Collaborator Lahey Hospital & Medical Center highlight the February issue of MedTech Strategist Market Pathways. Johnson & Johnson has nearly completed a proactive post-market surveillance for safety and effectiveness of Class II lumbar interbody system device procedures. Real-World Evidence gathered from this and other NESTcc Test-Cases […]
In June 2018, NESTcc established Data Quality and Methods Subcommittees to support its efforts to conduct efficient, timely, and high-quality real-world evidence (RWE) studies for medical devices. The 12-member Data Quality Subcommittee and 9-member Methods Subcommittee are composed of representatives from health systems, including NESTcc Network Collaborators, medical device manufacturers, academics, and the U.S. Food […]